These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2535855)

  • 1. Complement attack of altered outer membrane areas synthesized after inhibition of the 3-deoxy-D-manno-octulosonate pathway leads to cell death.
    Goldman RC; Miller MF
    J Immunol; 1989 Jan; 142(1):185-94. PubMed ID: 2535855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimeric C9 within C5b-9 deposits in unique locations in the cell wall of Salmonella typhimurium.
    Joiner KA; Tartanian AB; Hammer CH; Schweinle JE
    J Immunol; 1989 Jun; 142(12):4450-7. PubMed ID: 2656866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex.
    Kochi SK; Johnson RC; Dalmasso AP
    J Immunol; 1991 Jun; 146(11):3964-70. PubMed ID: 2033266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement resistance in Borrelia burgdorferi strain 297: outer membrane proteins prevent MAC formation at lysis susceptible sites.
    Patarakul K; Cole MF; Hughes CA
    Microb Pathog; 1999 Jul; 27(1):25-41. PubMed ID: 10371707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial killing and inhibition of inner membrane activity by C5b-9 complexes as a function of the sequential addition of C9 to C5b-8 sites.
    MacKay SL; Dankert JR
    J Immunol; 1990 Nov; 145(10):3367-71. PubMed ID: 2230122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement-mediated inhibition of function in complement-resistant Escherichia coli.
    Dankert JR
    J Immunol; 1989 Mar; 142(5):1591-5. PubMed ID: 2645364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of exogenous 3-deoxy-D-manno-octulosonate incorporation into lipid A precursor of toluene-treated Salmonella typhimurium cells.
    Capobianco JO; Darveau RP; Goldman RC; Lartey PA; Pernet AG
    J Bacteriol; 1987 Sep; 169(9):4030-5. PubMed ID: 3040673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanism of bacterial resistance to complement-mediated killing. IV. C5b-9 forms high molecular weight complexes with bacterial outer membrane constituents on serum-resistant but not on serum-sensitive Neisseria gonorrhoeae.
    Joiner KA; Warren KA; Brown EJ; Swanson J; Frank MM
    J Immunol; 1983 Sep; 131(3):1443-51. PubMed ID: 6411816
    [No Abstract]   [Full Text] [Related]  

  • 11. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.
    Tesh VL; Duncan RL; Morrison DC
    J Immunol; 1986 Aug; 137(4):1329-35. PubMed ID: 3525676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of resistance to complement-mediated killing of bacteria encoded by the Salmonella typhimurium virulence plasmid gene rck.
    Heffernan EJ; Reed S; Hackett J; Fierer J; Roudier C; Guiney D
    J Clin Invest; 1992 Sep; 90(3):953-64. PubMed ID: 1522243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of Actinobacillus pleuropneumoniae to bactericidal antibody and complement is mediated by capsular polysaccharide and blocking antibody specific for lipopolysaccharide.
    Ward CK; Inzana TJ
    J Immunol; 1994 Sep; 153(5):2110-21. PubMed ID: 8051416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sub-minimal inhibitory concentrations of cefmetazole enhance serum bactericidal activity in vitro by amplifying poly-C9 deposition.
    Schweinle JE; Nishiyasu M
    J Clin Invest; 1992 Apr; 89(4):1198-207. PubMed ID: 1556181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing.
    Joiner K; Brown E; Hammer C; Warren K; Frank M
    J Immunol; 1983 Feb; 130(2):845-9. PubMed ID: 6848598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sublytic complement attack exposes C-reactive protein binding sites on cell membranes.
    Li YP; Mold C; Du Clos TW
    J Immunol; 1994 Mar; 152(6):2995-3005. PubMed ID: 8144898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C5b-9 assembly: average binding of one C9 molecule to C5b-8 without poly-C9 formation generates a stable transmembrane pore.
    Bhakdi S; Tranum-Jensen J
    J Immunol; 1986 Apr; 136(8):2999-3005. PubMed ID: 3958488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
    Densen P; McRill CM; Ross SC
    J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane vesiculation of Naegleria fowleri amoebae as a mechanism for resisting complement damage.
    Toney DM; Marciano-Cabral F
    J Immunol; 1994 Mar; 152(6):2952-9. PubMed ID: 8144894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope.
    Weiss J; Muello K; Victor M; Elsbach P
    J Immunol; 1984 Jun; 132(6):3109-15. PubMed ID: 6373924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.